Latest Coronavirus Disease COVID 19 News and Research
Corralling the facts on herd immunity
For a term that's at least 100 years old, "herd immunity" has gained new life in 2020.
Computer model unravels mystery behind severe inflammation in people with COVID-19
A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation?
Efforts to keep COVID-19 out of prisons fuel outbreaks in county jails
When Joshua Martz tested positive for COVID-19 this summer in a Montana jail, guards moved him and nine other inmates with the disease into a pod so cramped that some slept on mattresses on the floor.
PrimeStore® MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation
EKF Diagnostics announces that the novel viral transport media PrimeStore® MTM has been successfully evaluated for effective SARS-CoV-2 inactivation.
How might India's monsoon season impact COVID-19 ?
A new study, by two Goethe University Frankfurt researchers, published on the preprint server medRxiv* in September 2020 explores the relationship between the monsoon season, the chances of exposure to ultraviolet B (UVB) radiation, and the COVID-19 mortality.
A special issue on the emerging COVID-19 infection
Acta Pharmaceutica Sinica B publishes special issue on 'Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)' edited by Hai-Bin Luo, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China; Shilin Chen, Institute of Chinese Materia Medica, Beijing, China and Peiqing Liu, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
Fear of COVID-19 can increase risk of substance abuse
Long after a COVID-19 vaccination is developed and years after the coronavirus death toll is tallied, the impact on mental health will linger, continuing to inflict damage if not addressed, according to new research.
Fasting blood glucose levels upon admission tied to COVID-19 prognosis, study finds
In the study, which appeared on the pre-print open-source medRxiv* server, the investigators aimed to determine the prognostic value of blood glucose in predicting outcomes in COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mental preparedness of nurses and nursing students in India for COVID-19
Researchers from Bengaluru, India, tried to assess the psychological preparedness of Indian nurses and nursing students in the face of the COVID-19 pandemic. The pandemic that has now affected over 33.27 million people worldwide seems to rage on unabated and is something that these healthcare workers have never faced before in their careers.
Smell and taste changes last longer than other COVID-19 symptoms
A preprint paper published on the medRxiv server details a recent study by researchers from The Hebrew University, Hadassah-Hebrew University medical center, and Hadassah University Hospital, which addresses this gap in knowledge about the symptoms experienced by COVID-19 patients.
SARS-CoV-2 re-infection is real but rare: Case study
Now, American researchers have looked at all reported cases of re-infection and the possible reasons behind them. Their study titled, “Re-infection with SARS-CoV-2 and Failure of Humoral Immunity: a case report,” is published online on the preprint server medRxiv in September 2020.
Healthy vitamin D levels could reduce COVID-19 complications
Published in the journal PLOS ONE, the study investigates the link between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes and parameters of immune function and mortality due to COVID-19.
New study reveals the impacts of COVID-19 on unborn children
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
One-third of parents in the U.S. won’t get flu shots for their kids during the pandemic
A survey from the National Poll on Children’s Health, however, revealed that one-third of American parents have no plans of getting their children vaccinated for the flu virus this year during the COVID-19 pandemic.
J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial
A multicenter phase 1/2a randomized, double-blinded, placebo-controlled clinical trial has been conducted recently to evaluate the safety, reactogenicity, and immunogenicity of a non-replicating adenovirus-based vaccine, namely Ad26.COV2.S against severe acute respiratory coronavirus 2 (SARS-CoV-2) infection.
Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days
A recent study by French researchers has demonstrated that experimental exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) is capable of inducing mild infection in hamsters and ferrets within 7 – 10 days of exposure. However, the infection completely resolves within 14 days. The study is currently available on the bioRxiv preprint server.
Resveratrol and pterostilbene inhibit SARS-CoV-2 infection in vitro
A team of scientists at the University of Groningen, in the Netherlands, demonstrates that a natural plant product, resveratrol, and its structural analog, pterostilbene, have long-lasting antiviral effects against severe acute respiratory coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv preprint server.
Science academies present joint statement on health, sustainability, and digitization
In the run-up to the summit of the G20 countries in November 2020 to be held in Riyadh (Saudi Arabia), the science academies of these countries have presented their joint statement "Foresight: Science for Navigating Critical Transitions".
Life-threatening COVID-19 associated with specific genetic variants
Results of a genome-wide association study on 2,244 critically-ill patients due to coronavirus disease (COVID-19) from 208 intensive care units across the United Kingdom revealed significant host-specific genetic determinants that can predispose people to the severe form of the disease. The report is currently available on the medRxiv preprint server.
Mapping the evolutionary profile of SARS-CoV-2 and COVID-19 using mutation order approach
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
No hay comentarios:
Publicar un comentario